David M Vail Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

8/2018	Phase II study of the oral selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in dogs with lymphoma.
11/2009	Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma.
5/2009	Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David M Vail Research Topics

Disease

26	Neoplasms (Cancer) 03/2021 - 08/2003
10	Lymphoma (Lymphomas) 03/2020 - 03/2002
6	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 08/2002
3	Disease Progression 03/2021 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2018
3	Melanoma (Melanoma, Malignant) 01/2021 - 08/2017
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2018 - 05/2009
3	Sarcoma (Soft Tissue Sarcoma) 12/2004 - 11/2002
2	Transitional Cell Carcinoma 01/2021 - 03/2004
2	Neutropenia 08/2009 - 09/2005
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Anorexia 08/2018
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2018
1	Hemangiosarcoma (Angiosarcoma) 06/2015
1	Hypercalcemia (Milk Alkali Syndrome) 01/2014
1	Cytopenia 01/2014
1	Multiple Myeloma 01/2014
1	Leukemia 01/2014
1	Mucositis 01/2013
1	Squamous Cell Carcinoma of Head and Neck 01/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2013
1	Pain (Aches) 01/2013
1	Toxic Optic Neuropathy 09/2010
1	Residual Neoplasm 06/2010
1	Fever (Fevers) 03/2010
1	Leukopenia 03/2010
1	Necrosis 03/2010
1	Inflammation (Inflammations) 03/2010
1	Anaphylaxis (Anaphylactic Shock) 01/2007
1	Osteomyelitis 09/2005
1	Rhinitis 09/2005
1	Osteonecrosis (Kienbock's Disease) 09/2005
1	Vomiting 09/2005
1	Diarrhea 09/2005
1	Starvation 07/2004

Drug/Important Bio-Agent (IBA)

7	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020 - 11/2002
5	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 08/2002
3	Biological ProductsIBA 01/2021 - 03/2010
3	Asparaginase (Elspar)FDA Link 03/2020 - 09/2005
3	rabacfosadineIBA 03/2020 - 05/2009
3	Liposomes (Liposome)IBA 12/2004 - 08/2002
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 08/2017
2	Prednisone (Sone)FDA LinkGeneric 08/2018 - 01/2007
2	Piroxicam (Feldene)FDA LinkGeneric 01/2015 - 03/2004
2	GuanineIBA 01/2014 - 05/2009
2	9-((2-phosphonylmethoxy)ethyl)guanineIBA 01/2014 - 05/2009
2	ProdrugsIBA 01/2014 - 05/2009
2	NucleotidesIBA 01/2014 - 05/2009
2	Cisplatin (Platino)FDA LinkGeneric 11/2004 - 08/2002
2	VaccinesIBA 07/2004 - 11/2002
1	lorukafusp alfaIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2020
1	pevonedistatIBA 09/2020
1	Proteins (Proteins, Gene)FDA Link 09/2020
1	Antineoplastic Agents (Antineoplastics)IBA 03/2020
1	verdinexorIBA 08/2018
1	DNA VaccinesIBA 08/2017
1	Monophenol Monooxygenase (Tyrosinase)IBA 08/2017
1	Contrast MediaIBA 01/2016
1	IodineIBA 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Melphalan (Alkeran)FDA LinkGeneric 01/2014
1	ParaproteinsIBA 01/2014
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	MutagensIBA 01/2013
1	NF-kappa B (NF-kB)IBA 01/2013
1	MTOR InhibitorsIBA 06/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2007
1	Estrogen ReceptorsIBA 09/2007
1	Lomustine (CCNU)FDA Link 01/2007
1	CobaltIBA 11/2006
1	VNP 20009 (VNP20009)IBA 07/2005
1	1-dodecylpyridoxal (PLD)IBA 12/2004
1	Pharmaceutical PreparationsIBA 12/2004
1	AlkaloidsIBA 07/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2004
1	Platelet-Derived Growth FactorIBA 07/2004
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2004
1	Becaplermin (PDGF-BB)FDA Link 07/2004

Therapy/Procedure

19	Therapeutics 01/2021 - 03/2002
13	Drug Therapy (Chemotherapy) 01/2021 - 11/2002
8	Radiotherapy 03/2021 - 03/2004
3	Surgical Amputation (Amputations) 01/2021 - 01/2009
2	Immunotherapy 08/2017 - 08/2003
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2010 - 12/2004
2	Combination Drug Therapy (Combination Chemotherapy) 01/2007 - 09/2005
1	Image-Guided Radiotherapy 03/2021
1	Injections 01/2021
1	Precision Medicine 01/2021
1	Cystectomy 01/2021
1	Aftercare (After-Treatment) 03/2020
1	Adjuvant Chemotherapy 12/2018
1	Enteral Nutrition (Feeding, Tube) 01/2013
1	Neoadjuvant Therapy 01/2009
1	CHOP protocol (VDCP protocol) 09/2005
1	Treatment Delay 09/2005